May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
"Neovascular Network Ingrowth Site Characterization in Polypoidal Choroidal Vasculopathy by Conventional Digital Indocyanine Green Angiography."
Author Affiliations & Notes
  • R.A. Costa
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
    Hospital de Olhos de Araraquara, U.D.A.T. – Unidade de Diagnostico Avancado e Tratamento, Araraquara, Brazil
  • E.V. Navajas
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • D. Calucci
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
    Hospital de Olhos de Araraquara, U.D.A.T. – Unidade de Diagnostico Avancado e Tratamento, Araraquara, Brazil
  • J.A. Cardillo
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
    Hospital de Olhos de Araraquara, U.D.A.T. – Unidade de Diagnostico Avancado e Tratamento, Araraquara, Brazil
  • M.E. Farah
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Footnotes
    Commercial Relationships  R.A. Costa, None; E.V. Navajas, None; D. Calucci, None; J.A. Cardillo, None; M.E. Farah, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3100. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.A. Costa, E.V. Navajas, D. Calucci, J.A. Cardillo, M.E. Farah; "Neovascular Network Ingrowth Site Characterization in Polypoidal Choroidal Vasculopathy by Conventional Digital Indocyanine Green Angiography." . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3100.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the feasibility of neovascular network ingrowth site identification in patients with polypoidal choroidal vasculopathy (PCV) by using a conventional high–resolution digital angiography device. Methods: Observational case series. Patients evaluated at a tertiary referral center with a diagnosis of PCV were invited to participate in a comprehensive ophthalmic evaluation, including best–corrected ETDRS visual acuity measurement, color fundus photography, and conventional angiographic studies (fluorescein and indocyanine green [ICG]). For the latter, a two–fold scheme of ICG dye infusion was utilized. The neovascular vessels (NVs) and PCV network ingrowth site were identified by comparing early– and late–phase ICG angiographic digital images to each other and to fluorescein angiograms. Results: Nineteen eyes of thirteen consecutive patients were studied. Early phase ICG angiography enabled clear identification of the PCV NVs in 18 out of 19 studied cases. Observation of the ICG dye–filling pattern within the PCV network revealed two distinct varieties of NVs. Typically, some NVs characterized by early filling (concomitant to the retinal arteries filling) and rapid transit (1.1 to 2.7 seconds) (Type A) were seen followed (1.0 to 1.9 seconds later) by the filling of several NVs in which an extended dye transit period was observed (7.8 seconds to several minutes) (Type B). The location of the PCV ingrowth site, based on the disposition of NVs Type A, was peripapillary in 12 eyes (mostly at the supero–temporal region), within de macular region in 5 eyes, and extra–macular in one. Focal treatment of the PCV ingrowth site by ICG–mediated photothrombosis led to immediate hypoperfusion of the entire PCV network in all 18 cases. Conclusions: By the use of a two–fold dye infusion scheme for conventional ICG angiography, identification of the neovascular network ingrowth site was achieved in 94.7% of the patients with PCV. Studies on the influence of focal treatment at such sites in the natural course of the disease are highly recommended.

Keywords: choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×